Hospitalist Clinical Performance Registry (H-CPR)
Committed to enhancing the quality of hospital-based care nationwide, we provide and share performance data with direct provider feedback to drive measurable improvements in patient care, while simplifying data abstraction.
Launched in 2015, H-CPR was among the first CMS approved QCDRs dedicated to inpatient and acute care. It offers clinical expertise in measure development in collaboration with the Society of Hospital Medicine (SHM).
Improving the Quality of Hospital-Based Care
- Clinical Quality Measures (CQMs)
- Promoting Interoperability Measures
- Improvement Activities
H-CPR also supports all MIPS Value Pathway (MVP). For full list including measures supported, see link.
H-CPR QCDR Measures
Our 2026 H-CPR Measures
View the detailed measure specifications for the Non-MIPS QCDR measures.
(Updated December 2025)
Scroll → to View
| Measure # | Measure Title | Hospitalist Measures | Post-Acute Care Measures | Critical Care Measures |
|---|---|---|---|---|
| HCPR24 | Appropriate Utilization of Vancomycin for Cellulitis |
✓ |
✓ |
|
| HCPR25 | Physician’s Orders for Life-Sustaining Treatment (POLST) Form |
✓ |
✓ |
✓ |
| HCPR27 | Point-of-Care Ultrasound: Evaluation for Pneumothorax after Central Venous Catheter (CVC) Placement |
✓ |
||
| HCPR28 | Heart Failure (HF): SGLT-2 Inhibitor Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
✓ |
✓ |
✓ |
| HCPR29 | Avoidance of DVT Ultrasound for Patients Diagnosed with Cellulitis |
✓ |
✓ |
|
| HCPR30 | Avoidance of Sliding-Scale Insulin Monotherapy for Admitted Diabetic Patients |
✓ |
✓ |
|
| HCPR31 | Point-of-Care Ultrasound for Evaluation and Management of Shock |
✓ |
||
| HCPR32 | Medication for Alcohol Use Disorder (MAUD) for Patients with Alcohol Use Disorder |
✓ |
✓ |
✓ |
| ECPR51 | Discharge Prescription of Naloxone after Opioid Poisoning or Overdose |
✓ |
||
| ECPR56 | Opioid Withdrawal: Initiation of Medication for Opioid Use Disorder (MOUD) and Referral to Outpatient Opioid Treatment |
✓ |
||
| ECPR58 | Patient-Reported Understanding of Discharge Diagnosis and Plan of Care |
✓ |
||
| ECPR59 | Patient Reported Trust in Provider |
✓ |
View measure specifications from previous years:
H-CPR Recommended MIPS Measures
Scroll → to View
| Measure # | Measure Title |
|---|---|
| 5 | Heart Failure: Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
| 6 | Heart Failure: Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
| 7 | Beta-Blocker Therapy-Prior MI or LVEF ≤40% |
| 8 | Heart Failure: Beta- Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
| 130 | Documentation of Current Medications in the Medical Record |
| 155 | Falls: Plan of Care |
Partner with Us
Learn more about our H-CPR QCDR and the measures we report on.